BlueStem Wealth Partners LLC Invests $1.80 Million in UnitedHealth Group Incorporated (NYSE:UNH)

BlueStem Wealth Partners LLC purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 3,563 shares of the healthcare conglomerate’s stock, valued at approximately $1,802,000.

A number of other institutional investors and hedge funds also recently modified their holdings of UNH. Hudson Value Partners LLC grew its holdings in UnitedHealth Group by 8.3% during the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock valued at $625,000 after purchasing an additional 82 shares during the period. Wealth Group Ltd. grew its holdings in UnitedHealth Group by 4.0% during the third quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock valued at $1,039,000 after purchasing an additional 68 shares during the period. Howard Capital Management Group LLC bought a new position in UnitedHealth Group during the third quarter valued at $341,000. GSG Advisors LLC grew its holdings in UnitedHealth Group by 14.4% during the third quarter. GSG Advisors LLC now owns 746 shares of the healthcare conglomerate’s stock valued at $435,000 after purchasing an additional 94 shares during the period. Finally, Campbell Wealth Management bought a new position in shares of UnitedHealth Group in the third quarter worth $230,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 1.4 %

UNH opened at $474.95 on Friday. The company has a market cap of $437.09 billion, a P/E ratio of 30.64, a P/E/G ratio of 1.37 and a beta of 0.61. The business’s 50-day moving average price is $516.59 and its 200-day moving average price is $557.04. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.83 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.77%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on UNH shares. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Oppenheimer raised their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Wells Fargo & Company cut their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Barclays dropped their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Finally, Stephens lifted their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $629.32.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.